{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:52:34Z","timestamp":1789602754654,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY11288"],"award-info":[{"award-number":["EY11288"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI071125"],"award-info":[{"award-number":["AI071125"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL109561"],"award-info":[{"award-number":["HL109561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR067182"],"award-info":[{"award-number":["AR067182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY022938"],"award-info":[{"award-number":["EY022938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veteran Affairs","doi-asserted-by":"crossref","award":["EY023286"],"award-info":[{"award-number":["EY023286"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"Department of Veteran Affairs","doi-asserted-by":"crossref","award":["EY11373"],"award-info":[{"award-number":["EY11373"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"Department of Veteran Affairs","doi-asserted-by":"crossref","award":["DK52855"],"award-info":[{"award-number":["DK52855"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.molimm.2017.06.036","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T10:45:31Z","timestamp":1504608331000},"page":"246-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["DAF in diabetic patients is subject to glycation\/inactivation at its active site residues"],"prefix":"10.1016","volume":"93","author":[{"given":"Rudolf","family":"Fl\u00fcckiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Cocuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram H.","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menachem","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Edward","family":"Medof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2017.06.036_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF03401659","article-title":"The transient pore formed by homologous terminal complement complexes functions as a bidirectional route for the transport of autocrine and paracrine signals across human cell membranes","volume":"2","author":"Acosta","year":"1996","journal-title":"Mol. Med."},{"key":"10.1016\/j.molimm.2017.06.036_bib0010","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/S0021-9258(19)89188-3","article-title":"Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein","volume":"261","author":"Ahmed","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.06.036_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.163.1.221","article-title":"Decay-accelerating factor is present on cultured human umbilical vein endothelial cells","volume":"163","author":"Asch","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2017.06.036_bib0020","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2337\/diabetes.52.7.1825","article-title":"Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors\/calcium-release channels","volume":"52","author":"Bidasee","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2017.06.036_bib0025","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.4049\/jimmunol.156.7.2528","article-title":"Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor","volume":"156","author":"Brodbeck","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.06.036_bib0030","first-page":"357","article-title":"Immunohistochemical localization of complement regulatory proteins in the human retina","volume":"27","author":"Fett","year":"2012","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.molimm.2017.06.036_bib0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2337\/db14-0215","article-title":"Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes","volume":"64","author":"Genuth","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2017.06.036_bib0040","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1074\/jbc.M410179200","article-title":"Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55)","volume":"280","author":"Harris","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.06.036_bib0045","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20041967","article-title":"Decay-accelerating factor modulates induction of T cell immunity","volume":"201","author":"Heeger","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2017.06.036_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbadis.2015.10.021","article-title":"D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts","volume":"1862","author":"Iannuzzi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2017.06.036_bib0055","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1016\/S0021-9258(18)67052-8","article-title":"Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites","volume":"261","author":"Iberg","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.06.036_bib0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.162.1.75","article-title":"Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria","volume":"162","author":"Kinoshita","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2017.06.036_bib0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/protein\/9.12.1143","article-title":"Molecular modeling and mechanism of action of human decay-accelerating factor","volume":"9","author":"Kuttner-Kondo","year":"1996","journal-title":"Protein Eng."},{"key":"10.1016\/j.molimm.2017.06.036_bib0070","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.4049\/jimmunol.167.4.2164","article-title":"Characterization of the active sites in decay-accelerating factor","volume":"167","author":"Kuttner-Kondo","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.06.036_bib0075","doi-asserted-by":"crossref","first-page":"18552","DOI":"10.1074\/jbc.M611650200","article-title":"Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases","volume":"282","author":"Kuttner-Kondo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.06.036_bib0080","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2008-04-151068","article-title":"Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis","volume":"112","author":"Lalli","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2017.06.036_bib0085","doi-asserted-by":"crossref","first-page":"146154","DOI":"10.1155\/2012\/146154","article-title":"Inflammation in diabetic nephropathy","volume":"2012","author":"Lim","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.molimm.2017.06.036_bib0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/joim.12338","article-title":"Complement regulators in human disease: lessons from modern genetics","volume":"277","author":"Liszewski","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.molimm.2017.06.036_bib0095","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.4049\/jimmunol.180.9.5882","article-title":"IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production","volume":"180","author":"Liu","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2017.06.036_bib0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1073\/pnas.0307200101","article-title":"Complement regulation at the molecular level: the structure of decay-accelerating factor","volume":"101","author":"Lukacik","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2017.06.036_bib0105","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","article-title":"Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes","volume":"160","author":"Medof","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2017.06.036_bib0110","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1021\/bi00370a003","article-title":"Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid","volume":"25","author":"Medof","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2017.06.036_bib0115","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1073\/pnas.84.7.2007","article-title":"Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement","volume":"84","author":"Medof","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2017.06.036_bib0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1096\/fasebj.10.5.8621057","article-title":"Cell-surface engineering with GPI-anchored proteins","volume":"10","author":"Medof","year":"1996","journal-title":"FASEB J."},{"issue":"Suppl. 5","key":"10.1016\/j.molimm.2017.06.036_bib0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ndt\/11.supp5.20","article-title":"Structure of advanced Maillard reaction products and their pathological role","volume":"11","author":"Monnier","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molimm.2017.06.036_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jdiacomp.2012.10.004","article-title":"The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes","volume":"27","author":"Monnier","year":"2013","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.molimm.2017.06.036_bib0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonzalez","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molimm.2017.06.036_bib0140","doi-asserted-by":"crossref","first-page":"18492","DOI":"10.1074\/jbc.274.26.18492","article-title":"Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts","volume":"274","author":"Oya","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.06.036_bib0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-4835(87)80011-8","article-title":"Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats","volume":"44","author":"Perry","year":"1987","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.molimm.2017.06.036_bib0150","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2337\/diabetes.53.10.2653","article-title":"Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes","volume":"53","author":"Qin","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2017.06.036_bib0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0167-4838(00)00133-3","article-title":"Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins","volume":"1481","author":"Sady","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2017.06.036_bib0160","doi-asserted-by":"crossref","first-page":"21597","DOI":"10.1016\/S0021-9258(20)88225-8","article-title":"Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process","volume":"264","author":"Sell","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2017.06.036_bib0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abbi.1997.0195","article-title":"Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct","volume":"344","author":"Shipanova","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molimm.2017.06.036_bib0170","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1073\/pnas.85.3.880","article-title":"Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells","volume":"85","author":"Stafford","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2017.06.036_bib0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2017.06.036_bib0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ni.2499","article-title":"Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells","volume":"14","author":"Strainic","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2017.06.036_bib0185","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/db16-0397","article-title":"Autophagy inhibits the accumulation of advanced glycation end products by promoting lysosomal biogenesis and function in the kidney proximal tubules","volume":"66","author":"Takahashi","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2017.06.036_bib0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.molimm.2017.06.036_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1016362923187","article-title":"Resonance assignments of the central complement control protein module pair of human decay accelerating factor","volume":"23","author":"Uhrinova","year":"2002","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.molimm.2017.06.036_bib0200","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1073\/pnas.0730844100","article-title":"Solution structure of a functionally active fragment of decay-accelerating factor","volume":"100","author":"Uhrinova","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2017.06.036_bib0205","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1462-5822.2007.00981.x","article-title":"Macrophage complement receptors and pathogen clearance","volume":"9","author":"van Lookeren Campagne","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.molimm.2017.06.036_bib0210","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/diab.35.8.916","article-title":"Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications","volume":"35","author":"Vishwanath","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.molimm.2017.06.036_bib0215","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0021-9258(18)48421-9","article-title":"Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells","volume":"267","author":"Walter","year":"1992","journal-title":"J. Biol. Chem."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017302080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589017302080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T09:07:01Z","timestamp":1692954421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589017302080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":43,"alternative-id":["S0161589017302080"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2017.06.036","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DAF in diabetic patients is subject to glycation\/inactivation at its active site residues","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2017.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}